Cites del registre

Cita APA (7th ed.)
Zatovkaňuková, P., Veselý, D., & Slíva, J. (2024). Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID<sup>®</sup>) with Concomitant Medications in Real-World Clinical Settings. MDPI AG.
Cita Chicago (17th ed.)
Zatovkaňuková, Petra, Dalibor Veselý, i Jiří Slíva. Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID<sup>®</sup>) with Concomitant Medications in Real-World Clinical Settings. MDPI AG, 2024.
Cita MLA (9th ed.)
Zatovkaňuková, Petra, et al. Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID<sup>®</sup>) with Concomitant Medications in Real-World Clinical Settings. MDPI AG, 2024.
Atenció: Aquestes cites poden no estar 100% correctes.